Академический Документы
Профессиональный Документы
Культура Документы
ABSTRACT INTRODUCTION
Background: The impact of dietary flavonoid intakes on risk of Depression is a major contributor to the global burden of
depression is unclear. disease- and illness-related disability (1). Although many patients
Objective: We prospectively examined associations between es-
Covariates
9
Abbreviations used: aMed, alternate Mediterranean diet; CESD-10, 10-item
We selected sociodemographic, lifestyle, and health/medical
version of the Center for Epidemiologic Studies Depression; FFQ, food-
frequency questionnaire; GDS-15, 15-item version of the Geriatric Depres- factors a priori on the basis of previous literature on depression
sion Scale; MHI-5, 5-item Mental Health Index; NHS, Nurses’ Health Study; risk factors (28) and our own preliminary data on risk indicators
NHSII, Nurses’ Health Study II; SSRI, selective serotonin reuptake inhibitor; of depression. Sociodemographic factors included age, census-
TCA, tricyclic antidepressant. tract median family income (a proxy of socioeconomic status),
706 CHANG ET AL.
social network index (29), and subjective social status (10-point meta-analyses by using random-effects models to obtain com-
visual analog scale of subjective feeling about standing in US bined estimates. Because the follow-up began in 2000 (NHS) or
society). Lifestyle variables included cigarette smoking, BMI (in 2001 (NHSII), but the closest information of dietary flavonoids
kg/m2), alcohol intake, coffee consumption (30), physical activity was collected in 1998 (NHS) or 1999 (NHSII), the analyses
[determined by using a validated assessment from which metabolic featured a 2-y outcome lag, which mitigated potential reverse
equivalents (metabolic equivalent-hours per week) could be causation (e.g., incipient depression may lead to changes in diet).
quantified] (31), and modified alternate Mediterranean diet (aMed) To address concerns of exposure misclassification, outcome
adherence (32) (excluding fruit, vegetable, and alcohol compo- misclassification, or competing risks, we performed 3 sensitivity
nents to avoid overadjustment). Health/medical covariates included analyses. First, we stopped updating diet after a report of incident
bodily pain, sleep problems (sleep difficulty and sleep duration), cancer (except for nonmelanoma skin cancer), cardiovascular
menopausal status, postmenopausal hormone use, multivitamin disease, or diabetes, because individuals may substantially alter
use, and medical comorbidities. Covariates were updated every their diet after diagnosis of a major disease; instead, the cumulative
2–4 y, as available. We carried forward the covariate information averages of flavonoid intakes up to the most recent dietary data
in the previous questionnaire cycle if missing during follow-up. before diagnosis of a major disease were carried forward thereafter.
Second, we applied alternative definitions of depression when
examining flavonoid-depression associations—including defini-
Sample for analysis tions based on the presence of both diagnosis and antidepressant
After the exclusion of participants with a missing baseline use (more strict definition), diagnosis only, or diagnosis or anti-
2000 or 2001 questionnaire, implausible daily energy intake depressant use including the use of TCAs (less strict definition).
(,600 or .3500 kcal/d), missing information on previous his- Third, it is possible that individuals with severe chronic diseases
1 3 5 1 3 5
cohort for other subclasses. Specifically, in the NHS, higher only in the NHS, with evidence of effect heterogeneity in several
intakes of total polymers and proanthocyanidins were signifi- quintile groups between cohorts.
cantly associated with a lower risk of depression (P-trend = 0.04 A sensitivity analysis, in which dietary information was no
and 0.03, respectively); yet, comparable results were not ob- longer updated after participants developed major chronic con-
served in the NHSII. Furthermore, a greater intake of total fla- ditions, yielded results similar to those in Table 2 (Supplemental
vonoids was associated with significantly lower depression risk Table 2). Results were similar when different outcome definitions
708 CHANG ET AL.
TABLE 2
HRs (95% CIs) for associations between flavonoid subclass intakes and incident depression among women in the NHS and the NHSII1
Quintile of intake
1 2 3 4 5 P-trend
Quintile of intake
1 2 3 4 5 P-trend
Meta-analyzed results
Random-effects model4 1.00 (referent) 0.97 (0.92, 1.04) 0.97 (0.91, 1.03) 0.95 (0.87, 1.00) 0.97 (0.91, 1.04) 0.64
P-heterogeneity 0.72 0.93 0.15 0.27 0.19
Anthocyanins, mg/d
NHS #5.9 .5.9–9.3 .9.3–13.4 .13.4–20.1 .20.1
Cases/person-years, n/n 1099/79,947 983/79,946 942/79,821 910/79,880 962/79,696
Model 12 1.00 (referent) 0.91 (0.83, 0.99) 0.89 (0.81, 0.97) 0.87 (0.79, 0.95) 0.94 (0.86, 1.03) 0.38
Model 23 1.00 (referent) 0.92 (0.85, 1.01) 0.92 (0.84, 1.00) 0.91 (0.83, 1.00) 1.00 (0.91, 1.10) 0.52
NHSII #6.3 .6.3–10.5 .10.5–15.3 .15.3–23.2 .23.2
Cases/person-years, n/n 1331/64,672 1253/64,563 1154/64,355 1105/64,292 1013/64,095
Model 12 1.00 (referent) 1.00 (0.92, 1.08) 0.95 (0.88, 1.03) 0.95 (0.87, 1.02) 0.92 (0.84, 1.00) 0.02
Model 23 1.00 (referent) 1.01 (0.93, 1.09) 0.97 (0.89, 1.05) 0.97 (0.89, 1.05) 0.95 (0.87, 1.04) 0.17
Meta-analyzed results
Random-effects model4 1.00 (referent) 0.97 (0.89, 1.06) 0.94 (0.89, 1.00) 0.94 (0.88, 1.00) 0.97 (0.91, 1.04) 0.70
P-heterogeneity 0.14 0.38 0.33 0.41 0.17
Polymeric flavonoids, mg/d
#96.3 .96.3–137.2 .137.2–190.9 .190.9–300.6 .300.6
were applied, but the 95% CIs were wider when the more strict years by 29% and 16% in the NHS and NHSII, respectively.
definition was used—likely due to the reduced numbers of cases However, findings from the competing risk analysis were similar
(Supplemental Table 3). We conducted a competing risk anal- to those from the primary analyses (Supplemental Table 4).
ysis, in which participants were censored when a major disease Finally, given the potential for confounding by other nutrients in
(cancer, heart disease, or diabetes) occurred; this reduced person- flavonoid-rich foods that may be associated with depression, we
710 CHANG ET AL.
performed additional analyses that further adjusted for intakes of different definitions of depression, the patterns of inverse associa-
omega-3 fatty acids, vitamin C, vitamin B-6, vitamin B-12, and tions between dietary flavonoids and late-life depression were
folate; the results were unchanged (data not shown). The results consistent. However, effect estimates appeared stronger, with nar-
remained the same when the aMed score adjusted for in the model rower 95% CIs, in analyses that incorporated depressive symptoms.
also included fruit and vegetable components (data not shown). For example, placement in quintile 5 (compared with quintile 1) for
We then conducted food-based analyses for the major sources of almost all flavonoid subclasses was related to significantly lower
the flavonoid subclasses that were significantly associated with depression risk, with evidence of linear trends. The exception was
lower depression risk in the pooled results in Table 2: flavonols, flavan-3-ols monomers (Table 4), which suggests that polymers of
flavones, and flavanones. The predominant flavone and flavanone flavan-3-ols may be more relevant than monomers to late-life de-
contributors, citrus (including orange and grapefruit) fruit and juices pression risk. The strongest associations were seen for flavones and
(33), were significantly inversely associated with depression risk proanthocyanidins (quintile 5 compared with quintile 1; HR for
in a dose-response fashion. Compared with citrus intake of ,1 both: 0.83; 95% CI: 0.77, 0.90). The complementary food-based
serving/wk, intakes of $2 servings/d were associated with an 18% analysis showed that higher intakes of apples/pears and citrus were
reduction in depression risk (Table 3); this association was con- associated with lower depression risk (P-trend = 0.002 and 0.02,
sistent in both cohorts. Both citrus fruit and juices were in- respectively) (Table 5).
dividually associated with lower depression risk (P-trend = 0.001
and 0.05, respectively); however, although moderate consumption DISCUSSION
of citrus fruit was related to lower depression risk, the significant To our knowledge, this is the first large-scale prospective study
association between citrus juice and lower depression risk was seen to examine the association between self-reported habitual intakes
only at the highest consumption amount. With regard to flavonols,
TABLE 3
Pooled HRs (95% CIs) for associations between intakes of flavonoid-rich food and incident depression among women in the NHS and the NHSII1
Intake category2
1 2 3 4 5 P-trend
Citrus fruit and juice results 1.00 (referent) 0.94 (0.85, 1.05) 0.89 (0.78, 1.02) 0.85 (0.75, 0.97) 0.82 (0.74, 0.91) ,0.0001
Citrus fruit 1.00 (referent) 0.93 (0.88, 0.99) 0.91 (0.86, 0.96) 0.97 (0.83, 1.13) 0.87 (0.75, 1.01) 0.001
Citrus juice 1.00 (referent) 0.99 (0.88, 1.12) 0.98 (0.92, 1.05) 0.96 (0.88, 1.04) 0.90 (0.82, 0.98) 0.05
Tea 1.00 (referent) 0.96 (0.90, 1.02) 0.98 (0.92, 1.04) 0.96 (0.90, 1.03) 0.88 (0.78, 1.00) 0.30
Onions 1.00 (referent) 1.00 (0.94, 1.06) 0.98 (0.92, 1.05) 0.96 (0.89, 1.02) 0.99 (0.89, 1.09) 0.25
1
n = 82,643. Depression was assessed by either self-reported physician diagnosis or regular use of antidepressant medication. HRs (95% CIs) for
depression by intake category of total flavonoids and individual subclasses of flavonoids were analyzed by using Cox proportional hazards models. The test for
trend was performed by using the median value for each intake category. Model adjusted for age, questionnaire cycle, total energy intake (continuous), social
network (quintiles), alternate Mediterranean diet score (quintiles), census-tract family income (,$50,000, $50,000–69,999, or $$70,000/y), alcohol intake
(0, 0.1–4.9, 5.0–29.9, 30–44.9, or $45.0 g/d), subjective self-rated societal position (low or other), cigarette smoking (never; past; current: 1–14, 15–24, or
$25 cigarettes/d), BMI (continuous), physical activity in total metabolic equivalents per week (continuous), actual sleep hours (#6, 7–8, or $9 h/d),
frequency of difficulty falling or staying asleep (none, little, or some to all of the time), bodily pain (none to mild or moderate to very severe), current
multivitamin use (yes or no), coffee consumption (#1 serving/wk, 2–6 servings/wk, 1 serving/d, 2–3 servings/d, or $4 servings/d), menopausal status and
postmenopausal hormone use [premenopausal or postmenopausal (never postmenopausal hormone user, past postmenopausal hormone user, or current
postmenopausal hormone user)], history of hypertension (yes or no), history of cardiovascular disease (yes or no), history of diabetes (yes or no), and history
of hypercholesterolemia (yes or no). Data were meta-analyzed using random-effects models. NHS, Nurses’ Health Study; NHSII, Nurses’ Health Study II.
2
Category values were as follows—citrus fruit and juice, citrus fruit, and citrus juice: 1 (,1 serving/wk), 2 (1 serving/wk), 3 (2–6 servings/wk),
4 (1 serving/d), and 5 ($2 servings/d); tea: 1 (,1 serving/mo), 2 ($1 serving/mo to #1 serving/wk), 3 (2–6 servings/wk), 4 (1–3 servings/d), and
5 ($4 servings/d); onion: 1 (,1 serving/mo), 2 (1–3 servings/mo), 3 (1 serving/wk), 4 (2–4 servings/wk), and 5 ($5 servings/wk). One serving = 1 orange,
one-half grapefruit, 1 small glass of orange juice, 1 small glass of grapefruit juice, 1 cup (240 mL) tea, or 0.5 cup onions.
DIETARY FLAVONOIDS AND DEPRESSION 711
TABLE 4
HRs (95% CIs) for associations between flavonoid subclass intakes and incident late-life depression among women in the NHS, aged $65 y1
Quintile of intake
1 2 3 4 5 P-trend
importance of these findings, several points can be highlighted. Available evidence with regard to flavonoid-depression as-
First, despite modest effect estimates, at a population level the sociations is limited, particularly data from epidemiologic studies
results may be important. By using a population-attributable risk and trials. Existing work has focused on intakes of a specific
framework, 5% of the depression cases that occurred in both the flavonoid-rich food (typically, cocoa or tea) or overall fruit and
NHS and NHSII could have been prevented if all women in the vegetable consumption. Inverse associations were observed in
lowest 3 quintiles of flavanone intakes switched to the highest 2 some studies, but most were cross-sectional and did not involve
quintile of intakes. Importantly, such computations require as- comprehensive evaluations of flavonoid subclasses or a broad
sumptions of causal links, which can only be established in range of food sources (36–38). Moreover, our results are in line
randomized trials or other experimental approaches; thus, with evidence of favorable relations of flavonoids to other later-
population-attributable risk estimates are more speculative in life brain outcomes, including cognitive decline and Parkinson
observational studies. Nevertheless, they are helpful at conveying disease (13, 17). Finally, preliminary evidence from randomized
the broader concept that small effect estimates from a common controlled trials suggested benefits of specific flavonoid com-
exposure can translate to relatively larger impacts on health. pounds for reducing depressive symptoms or enhancing mood
Second, although the magnitudes of overall estimates of asso- (39, 40). However, most of these randomized controlled trials
ciation were modest in the primary analysis, the associations focused on short-term action of flavonoids on change in de-
were stronger with respect to late-life depression. For example, pressive symptoms and had small sample sizes. Overall, there is
women in the highest quintile of flavones and proanthocyanidins no comparable evidence with regard to whether long-term habitual
showed a significant 17% reduction in the risk of late-life depression. intakes of flavonoids affect depression risk. Thus, the current
Third, the significant dose-response relation and consistency study makes a unique contribution to the literature.
across 2 cohorts for several specific flavonoids made the observed Although the specific links between flavonoids and depression
inverse associations less likely to be due to chance. are unclear, growing evidence supports a beneficial role for
712 CHANG ET AL.
TABLE 5
HRs (95% CIs) for associations between intakes of flavonoid-rich food and incident late-life depression among women aged $65 y in the NHS1
Intake category2
1 2 3 4 5 P-trend
Citrus fruit and juices 1.00 (referent) 0.90 (0.75, 1.09) 0.88 (0.76, 1.01) 0.90 (0.77, 1.05) 0.84 (0.72, 0.97) 0.02
Tea 1.00 (referent) 1.02 (0.94, 1.11) 0.96 (0.89, 1.04) 0.98 (0.90, 1.07) 0.88 (0.75, 1.04) 0.11
Onions 1.00 (referent) 0.98 (0.89, 1.06) 1.01 (0.92, 1.10) 0.96 (0.88, 1.05) 0.93 (0.82, 1.04) 0.22
Apples or pears 1.00 (referent) 0.99 (0.83, 1.18) 0.91 (0.76, 1.09) 0.92 (0.77, 1.09) 0.84 (0.71, 1.01) 0.002
Strawberries 1.00 (referent) 0.99 (0.87, 1.12) 0.97 (0.85, 1.09) 0.95 (0.84, 1.08) 0.92 (0.73, 1.14) 0.22
Blueberries 1.00 (referent) 0.96 (0.90, 1.02) 0.95 (0.88, 1.02) 0.97 (0.88, 1.08) 0.70 (0.46, 1.07) 0.17
Red wine 1.00 (referent) 1.03 (0.96, 1.10) 0.98 (0.90, 1.08) 0.91 (0.83, 1.01) 0.94 (0.81, 1.08) 0.09
1
n = 41,920. HRs (95% CIs) for depression by intake category of total flavonoids and individual subclasses of flavonoids were analyzed by using Cox
proportional hazards models. The test for trend was performed by using the median value for each intake category. Model adjusted for age, questionnaire
cycle, total energy intake (continuous), social network (quintiles), alternate Mediterranean diet score (quintiles), census-tract family income (,$50,000,
$50,000–69,999, or $$70,000/y), alcohol intake (0, 0.1–4.9, 5.0–29.9, 30–44.9, or $45.0 g/d), subjective self-rated societal position (low or other), cigarette
smoking (never; past; current: 1–14, 15–24, or $25 cigarettes/d), BMI (continuous), physical activity in total metabolic equivalents per week (continuous),
actual sleep hours (#6, 7–8, or $9 h/d), frequency of difficulty falling or staying asleep (none, little, or some to all of the time), bodily pain (none to mild or
moderate to very severe), current multivitamin use (yes or no), coffee consumption (#1 serving/wk, 2–6 servings/wk, 1 serving/d, 2–3 servings/d, or $4 servings/d),
menopausal status and postmenopausal hormone use [premenopausal or postmenopausal (never postmenopausal hormone user, past postmenopausal hormone user,
or current postmenopausal hormone user)], history of hypertension (yes or no), history of cardiovascular disease (yes or no), history of diabetes (yes or no), and
flavonoids on mood and brain health (41, 42), and direct and analytic extraction methods (54). In addition, some foods with
indirect mechanisms have been suggested (43). Direct mecha- different flavonoid contents are grouped together into single
nisms may include modulating signaling pathways responsible questions (e.g., apples and pears are grouped together, and black
for maintaining neuron survival and inducing synaptic plasticity and green teas are not differentiated in the NHS/NHSII FFQs).
(7, 42, 44). Indirect mechanisms may include reducing neuro- Therefore, some degree of exposure misclassification is likely.
inflammation, improving blood flow, or reducing oxidative stress However, the quartile ranking is less likely to be affected by such
(6, 8, 9, 45). However, it is unclear whether the different flavonoid misclassification, and fruit and vegetable intakes assessed from
subclasses and their metabolites share generic neuroprotection an FFQ and weighted diet records correlated well in repro-
properties or whether particular flavonoids are more neuro- ducibility and validity studies in the NHS and NHSII cohorts
protective than others. It is important to note that, although many (19–21). Although we did not have objective biomarkers of
flavonoid metabolites are shown to cross the blood-brain barrier flavonoid intakes, such as urinary metabolite excretion, mea-
(46, 47), the beneficial effects of specific flavonoids may depend sured in this study, good correlations between flavonoid biomarker
on their bioavailability—influenced by absorption, metabolism, and concentrations and fruit/vegetable intakes (0.43–0.66) have been
disposition in tissues and cells—which differs greatly by subclasses reported elsewhere (55). Potential misclassification of the de-
(48, 49). For example, flavanones are more efficiently absorbed pression outcome must also be considered, despite past success
than most other subclasses and have longer elimination half-lives in using this definition to show important disease associations
(50). Among the older cohort (i.e., NHS), polymers including (26). For example, some degree of underascertainment of de-
proanthocyanidins were also associated with lower depression risk. pression in this study is likely, because participants’ physicians
Although the full range of biological mechanisms of flavonoids or clinicians may not detect depression when it is present, cli-
involved in depression remains to be elucidated, proanthocyanidin- nicians may not inform participants of the depression diagnosis,
rich botanical extracts have been shown to prevent depressive-like or participants may elect not to report on the questionnaires the
behaviors in proneurotoxin-treated rats and to promote anti- depression diagnoses they received or their antidepressant use
inflammatory and antioxidant activities in rats (51, 52). information. However, the rates we observed are consistent with
Strengths of this study include the following: a large sample previously reported rates for major depression in women (34,
size; its prospective design; a comprehensive assessment of the 35). The rate observed for the broader depression definition in
full range of flavonoid subclasses in habitual diet; long-term, older women (diagnosis, treatment, and/or symptoms) is almost
detailed, and repeated measures of flavonoids and covariates; and identical to that reported elsewhere when depression is similarly
lengthy follow-up. Limitations also warrant discussion. For defined (34, 35). The use of the more conservative, clinical
example, it is impossible to include every single food and nutrient indicators-only outcome definition may bias results toward the
in the FFQ, and flavonoid values calculated from the most recent null; therefore, our primary analysis results may be underestimates.
databases (11) could be misclassified because flavonoid contents In addition, SSRIs are prescribed not only for depression but also
of foods vary by growth and processing conditions (53) and for other psychiatric conditions; this may generate false-positive
DIETARY FLAVONOIDS AND DEPRESSION 713
depression cases. Some true depression cases may also have been 3. Reynolds CF III, Cuijpers P, Patel V, Cohen A, Dias A, Chowdhary N,
missed because regular use of TCAs (,3% in both the NHS and Okereke OI, Dew MA, Anderson SJ, Mazumdar S, et al. Early in-
tervention to reduce the global health and economic burden of major
NHSII) was not included in the outcome definition. However, the depression in older adults. Annu Rev Public Health 2012;33:123–35.
probability of correctly classifying individuals as cases is likely to 4. Stahl ST, Albert SM, Dew MA, Lockovich MH, Reynolds CF III.
be independent of flavonoid intake and thus should not bias the Coaching in healthy dietary practices in at-risk older adults: a case of
observed associations. Indeed, the results from the sensitivity indicated depression prevention. Am J Psychiatry 2014;171:499–505.
5. Sanhueza C, Ryan L, Foxcroft DR. Diet and the risk of unipolar de-
analyses applying more or less strict definitions showed similar pression in adults: systematic review of cohort studies. J Hum Nutr
findings. Diet 2013;26(1):56–70.
Other potential methodologic limitations should be discussed. 6. Vafeiadou K, Vauzour D, Lee HY, Rodriguez-Mateos A, Williams RJ,
First, despite careful adjustment for potential confounders, residual Spencer JP. The citrus flavanone naringenin inhibits inflammatory
signalling in glial cells and protects against neuroinflammatory injury.
confounding is possible. Nevertheless, the detailed, updated ad-
Arch Biochem Biophys 2009;484:100–9.
justment for covariates render residual confounding unlikely to 7. Spencer JP. Flavonoids and brain health: multiple effects underpinned
account fully for the findings. We also cannot rule out that other by common mechanisms. Genes Nutr 2009;4:243–50.
dietary components in fruit and vegetables may affect the results. 8. Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A,
However, further adjustment for omega-3 fatty acid and vitamin C, Mazur A. Hesperidin contributes to the vascular protective effects of
orange juice: a randomized crossover study in healthy volunteers. Am J
B-6, and B-12 or folate intakes did not attenuate the associations; Clin Nutr 2011;93:73–80.
in addition, the results remained the same when we adjusted for the 9. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA,
aMed score in the model (which includes fruit and vegetable Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and
components). Second, our results could be biased if the censoring cardiovascular risk: a meta-analysis of randomized controlled trials.
Am J Clin Nutr 2008;88:38–50.
mechanism was dependent on the mechanism that produced the 10. Santos M, Kovari E, Hof PR, Gold G, Bouras C, Giannakopoulos P.